PB2501: INSIGHT-1: A PHASE I FIRST-IN-HUMAN TCR TRIAL OF GENETICALLY MODIFIED T-CELLS TARGETING TDT IN CHILDREN AND ADULTS WITH T- AND B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA/LYMPHOMA...

por Buechner, Jochen, Holth Rustad, Even, Meyer, Saskia, Gjerdingen, Thea, Giannakopoulou, Eirini, Ali, Muhammad, Weum Abrahamsen, Ingerid, Pasetto, Anna, Yuan, Ying, Olweus, Johanna
Publicado 2023

A systematic safety pipeline for selection of T-cell receptors to enter clinical use

por Foldvari, Zsofia, Knetter, Cathrine, Yang, Weiwen, Gjerdingen, Thea Johanne, Bollineni, Ravi Chand, Tran, Trung The, Lund-Johansen, Fridtjof, Kolstad, Arne, Drousch, Kimberley, Klopfleisch, Robert, Leisegang, Matthias, Olweus, Johanna
Publicado 2023

A T cell receptor targeting a recurrent driver mutation in FLT3 mediates elimination of primary human acute myeloid leukemia in vivo

por Giannakopoulou, Eirini, Lehander, Madeleine, Virding Culleton, Stina, Yang, Weiwen, Li, Yingqian, Karpanen, Terhi, Yoshizato, Tetsuichi, Rustad, Even H., Nielsen, Morten Milek, Bollineni, Ravi Chand, Tran, Trung T., Delic-Sarac, Marina, Gjerdingen, Thea Johanne, Douvlataniotis, Karolos, Laos, Maarja, Ali, Muhammad, Hillen, Amy, Mazzi, Stefania, Chin, Desmond Wai Loon, Mehta, Adi, Holm, Jeppe Sejerø, Bentzen, Amalie Kai, Bill, Marie, Griffioen, Marieke, Gedde-Dahl, Tobias, Lehmann, Sören, Jacobsen, Sten Eirik W., Woll, Petter S., Olweus, Johanna
Publicado 2023